NMDA

CAS No. 6384-92-5

NMDA ( LC488A; LC 488A; LC-488A )

Catalog No. M18940 CAS No. 6384-92-5

N-Methyl-D-aspartic acid is an amino acid that, as the D-isomer, is the defining agonist for the NMDA receptor subtype of glutamate receptors.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 32 In Stock
50MG 45 In Stock
100MG 61 In Stock
200MG 105 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NMDA
  • Note
    Research use only, not for human use.
  • Brief Description
    N-Methyl-D-aspartic acid is an amino acid that, as the D-isomer, is the defining agonist for the NMDA receptor subtype of glutamate receptors.
  • Description
    LC-488A is a prototypic agonist at the NMDA-type glutamate receptor that regulates ion channels; important in long-term potentiation, ischemia, and epilepsy.
  • Synonyms
    LC488A; LC 488A; LC-488A
  • Pathway
    MAPK/ERK Signaling
  • Target
    ERK
  • Recptor
    NMDA receptor
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    6384-92-5
  • Formula Weight
    147.13
  • Molecular Formula
    C5H9NO4
  • Purity
    98%
  • Solubility
    DMSO : 15 mg/mL 101.95 mM;
  • SMILES
    CN[C@H](CC(=O)O)C(=O)O
  • Chemical Name
    N-Methyl-D-aspartic acid

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Cull-Candy S, et al. Curr Opin Neurobiol, 2001, 11(3), 327-335.
molnova catalog
related products
  • NVP 231

    NVP-231 is a potent, specific, and reversible CerK inhibitor(IC50=12±2 nM) that competitively inhibits binding of ceramide to CerK.

  • MK-8353 hydrochlorid...

    MK-8353 hydrochloride (SCH-900353) is a highly potent, orally bioavailable, dual-specificity ERK1/2 inhibitor with IC50 of 23.0/8.8 nM, respectively.

  • ERK-IN-3

    ERK-IN-3 is a potent and orally active inhibitor of ERK. It inhibits ERK1/2 with low single-digit nM IC50 values. It can be used for the research of cancers driven by RAS mutations.